Interleukin-10: an anti-inflammatory cytokine with therapeutic potential (Q33723684)

28 July 2017

1 reference

title

Interleukin-10: an anti-inflammatory cytokine with therapeutic potential (English)

1 reference

28 July 2017

0 references

Pretolani M

1 reference

28 July 2017

publication date

1 September 1999

1 reference

Clinical & Experimental Allergy

28 July 2017

published in

1 reference

28 July 2017

1 reference

28 July 2017

1 reference

28 July 2017

page(s)

1164-1171

1 reference

The human interleukin-10 receptor gene maps to chromosome 11q23.3.

28 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.1999.00456.X

Characterization of recombinant extracellular domain of human interleukin-10 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.1999.00456.X

Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.1999.00456.X

Interleukin-10: Biology, Role in Inflammation and Autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.1999.00456.X

Interleukin-10: actions and therapeutic potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.1999.00456.X

In vivo induction of interleukin 10 by anti-CD3 monoclonal antibody or bacterial lipopolysaccharide: differential modulation by cyclosporin A

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.1999.00456.X

Interleukin 10 (IL-10) upregulates IL-1 receptor antagonist production from lipopolysaccharide-stimulated human polymorphonuclear leukocytes by delaying mRNA degradation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.1999.00456.X

Eosinophilic Inflammation in Asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.1999.00456.X

Interleukin 5 deficiency abolishes eosinophilia, airways hyperreactivity, and lung damage in a mouse asthma model

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.1999.00456.X

IL-10: a potential therapy for allergic inflammation?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.1999.00456.X

GM-CSF, IL-3 and IL-5: cross-competition on human haemopoietic cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.1999.00456.X

Chemokines and leukocyte traffic

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.1999.00456.X

Kinetics of eotaxin generation and its relationship to eosinophil accumulation in allergic airways disease: analysis in a guinea pig model in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.1999.00456.X

Eosinophil recruitment to the lung in a murine model of allergic inflammation. The role of T cells, chemokines, and adhesion receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.1999.00456.X

Interleukin 10 inhibits lipopolysaccharide-induced survival and cytokine production by human peripheral blood eosinophils

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.1999.00456.X

CD40 expression by human peripheral blood eosinophils

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.1999.00456.X

Pulmonary immune cells in health and disease: mast cells and basophils

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.1999.00456.X

Mast cells as a source of both preformed and immunologically inducible TNF-alpha/cachectin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.1999.00456.X

Interleukin 10: a novel stimulatory factor for mast cells and their progenitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.1999.00456.X

Interleukin (IL)-10 inhibits long-term IL-6 production but not preformed mediator release from rat peritoneal mast cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.1999.00456.X

Interleukin-10 inhibits antigen-induced cellular recruitment into the airways of sensitized mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.1999.00456.X

Interleukin-10 gene knock-out mice: a model of chronic inflammation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.1999.00456.X

Interleukin-10 is a natural suppressor of cytokine production and inflammation in a murine model of allergic bronchopulmonary aspergillosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.1999.00456.X

Interleukin 10 but not interleukin 4 is a natural suppressant of cutaneous inflammatory responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.1999.00456.X

Interferon gamma regulates antigen-induced eosinophil recruitment into the mouse airways by inhibiting the infiltration of CD4+ T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.1999.00456.X

Murine eotaxin: an eosinophil chemoattractant inducible in endothelial cells and in interleukin 4-induced tumor suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.1999.00456.X

Mechanisms of action of glucocorticoids in asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.1999.00456.X

Peripheral blood CD4 but not CD8 t-lymphocytes in patients with exacerbation of asthma transcribe and translate messenger RNA encoding cytokines which prolong eosinophil survival in the context of a Th2-type pattern: effect of glucocorticoid therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.1999.00456.X

A pilot trial of recombinant human interleukin-10 in kidney transplant recipients receiving OKT3 induction therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.1999.00456.X

IL-10 is a key cytokine in psoriasis. Proof of principle by IL-10 therapy: a new therapeutic approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.1999.00456.X

The effects of inhaled interferon gamma in normal human airways

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.1999.00456.X

Role of interleukin 10 in the B lymphocyte hyperactivity and autoantibody production of human systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.1999.00456.X

Interleukin 10 is a potent growth and differentiation factor for activated human B lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.1999.00456.X

10.1046/J.1365-2222.1999.00456.X

21 January 2018

Identifiers

DOI

1 reference

28 July 2017

1 reference